The short version
5 companies supply this market — a reasonable cushion if one runs into trouble.
Market view
gabapentin enacarbil · Powder
5 marketed package NDCs · 5 active manufacturers
Most dispensed: 300 mg · Tablet, Extended Release · #30 tablet, extended releases/bottle, plastic · 600 mg · Tablet, Extended Release · #30 tablet, extended releases/bottle, plastic
What changed in the last 90 days
Every detected change for gabapentin enacarbil, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
Common questions
- Is Gabapentin enacarbil in shortage right now?
- No. FDA does not currently list Gabapentin enacarbil in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Gabapentin enacarbil?
- 6 companies have marketed Gabapentin enacarbil in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Gabapentin enacarbil cost?
- The typical pharmacy pays about $17.93 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.